![Immunohistochemistry: Secretory phospholipase A2 Type V Antibody [NBP2-31558] - Lung cancer express human group V (hGV) and neutrophils (CD66b+ cells). Sections of non-tumor (A-D) and tumor lung tissues (E-H) were stained for hGV [(C,D,G,H); brown] or CD66b [(A,B,E,F); brown]. Panels (B,D,F,H) display higher magnification (20x) of panels (A,C,E,G) (10x), respectively. Image collected and cropped by CiteAb from the following publication (journal.frontiersin.org/article/10.3389/fimmu.2017.00443/full), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Secretory-phospholipase-A2-Type-V-Antibody-Immunohistochemistry-NBP2-31558-img0010.jpg "Immunohistochemistry: Secretory phospholipase A2 Type V Antibody [NBP2-31558] - Lung cancer express human group V (hGV) and neutrophils (CD66b+ cells). Sections of non-tumor (A-D) and tumor lung tissues (E-H) were stained for hGV [(C,D,G,H); brown] or CD66b [(A,B,E,F); brown]. Panels (B,D,F,H) display higher magnification (20x) of panels (A,C,E,G) (10x), respectively. Image collected and cropped by CiteAb from the following publication (journal.frontiersin.org/article/10.3389/fimmu.2017.00443/full), licensed under a CC-BY license.")
| Reactivity | HuSpecies Glossary |
| Applications | IHC |
| Clonality | Polyclonal |
| Host | Rabbit |
| Conjugate | Unconjugated |
| Immunogen | This antibody was developed against a recombinant protein corresponding to amino acids: GLLDLKSMIEKVTGKNALTNYGFYGCYC |
| Isotype | IgG |
| Clonality | Polyclonal |
| Host | Rabbit |
| Gene | PLA2G5 |
| Purity | Immunogen affinity purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Dilutions |
|
||
| Application Notes | For IHC-Paraffin, HIER pH 6 retrieval is recommended. |
||
| Control Peptide |
|
||
| Publications |
|
| Storage | Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
| Buffer | PBS (pH 7.2) and 40% Glycerol |
| Preservative | 0.02% Sodium Azide |
| Purity | Immunogen affinity purified |
![Western Blot PLA2G2A Antibody [Unconjugated]](https://images.novusbio.com/images2/PLA2G2A_AF4925_Western_Blot_10430.jpg)
![Immunohistochemistry PLA2G2A Antibody [Unconjugated]](https://images.novusbio.com/images2/PLA2G2A_AF4925_Immunohistochemistry_10959.jpg)
![Simple Western PLA2G2A Antibody [Unconjugated]](https://images.novusbio.com/images2/PLA2G2A_AF4925_Simple_Western_17643.jpg)
| Publication using NBP2-31558 | Applications | Species |
|---|---|---|
| Loffredo S, Borriello F, Iannone R et al. Group V Secreted Phospholipase A2 Induces the Release of Proangiogenic and Antiangiogenic Factors by Human Neutrophils. Front Immunol. 2017-05-01 [PMID: 28458672] (IHC-P, Human) | IHC-P | Human |
Secondary Antibodies |
Isotype Controls |
Research Areas for Secretory phospholipase A2 Type V Antibody (NBP2-31558)Find related products by research area.
|
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
![Immunohistochemistry-Paraffin: Secretory phospholipase A2 Type V Antibody [NBP2-31558] - Staining of human retina shows strong cytoplasmic positivity in photoreceptor cells.](http://images.novusbio.com/fullsize/Secretory-phospholipase-A2-Type-V-Antibody-Immunohistochemistry-Paraffin-NBP2-31558-img0009.jpg "Immunohistochemistry-Paraffin: Secretory phospholipase A2 Type V Antibody [NBP2-31558] - Staining of human retina shows strong cytoplasmic positivity in photoreceptor cells.")
![Lung cancer express human group V (hGV) and neutrophils (CD66b+ cells). Sections of non-tumor (A–D) and tumor lung tissues (E–H) were stained for hGV [(C,D,G,H); brown] or CD66b [(A,B,E,F); brown]. Panels (B,D,F,H) display higher magnification (20×) of panels (A,C,E,G) (10×), respectively.](http://images.novusbio.com/fullsize/nbp2-31558_rabbit-polyclonal-secretory-phospholipase-a2-type-v-antibody-271220231261939.jpg "Lung cancer express human group V (hGV) and neutrophils (CD66b+ cells). Sections of non-tumor (A–D) and tumor lung tissues (E–H) were stained for hGV [(C,D,G,H); brown] or CD66b [(A,B,E,F); brown]. Panels (B,D,F,H) display higher magnification (20×) of panels (A,C,E,G) (10×), respectively.")
![Simple Western 14-3-3 zeta Antibody (818515) [Unconjugated]](https://images.novusbio.com/images2/1433_zeta_MAB2669_Simple_Western_16526.jpg)
![Western Blot 14-3-3 zeta Antibody (818515) [Unconjugated]](https://images.novusbio.com/images2/14-3-3_zeta_MAB2669_Western_Blot_12700.jpg)
![Immunohistochemistry 14-3-3 zeta Antibody (818515) [Unconjugated]](https://images.novusbio.com/images2/14-3-3_zeta_MAB2669_Immunohistochemistry_12730.jpg)
![Western Blot PEDFR/PNPLA2/ATGL Antibody [Unconjugated]](https://images.novusbio.com/images2/PEDF_R_AF5365_Western_Blot_5700.jpg)
![Simple Western PEDFR/PNPLA2/ATGL Antibody [Unconjugated]](https://images.novusbio.com/images2/PEDF_R_AF5365_Simple_Western_17547.jpg)
![Immunohistochemistry PEDFR/PNPLA2/ATGL Antibody [Unconjugated]](https://images.novusbio.com/images2/PEDF_R_AF5365_Immunohistochemistry_6870.jpg)
![Western Blot ERK2 Antibody [Unconjugated]](https://images.novusbio.com/images2/ERK2_AF1230_Western_Blot_5097.jpg)
![Immunohistochemistry ERK2 Antibody [Unconjugated]](https://images.novusbio.com/images2/ERK2_AF1230_Immunohistochemistry_20696.jpg)
![Knockout Validated ERK2 Antibody [Unconjugated]](https://images.novusbio.com/images2/ERK2_AF1230_Knockout_Validated_22864.jpg)
![SDS-PAGE TNF-alpha [Unconjugated]](https://images.novusbio.com/images2/TNF-alpha_210-TA_256.jpg)
![Bioactivity TNF-alpha [Unconjugated]](https://images.novusbio.com/images2/TNFalpha_210TA_1658.jpg)
![SEC-MALS TNF-alpha [Unconjugated]](https://images.novusbio.com/images/210-ta_recombinant-human-tnf-alpha-protein-sec-mals-35202312244..jpg)
![Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).](https://images.novusbio.com/images/Goat-anti-Rabbit-IgG-H+L-Secondary-Antibody-HRP-Western-Blot-NB7160-img0001.jpg "Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).")
![Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.](https://images.novusbio.com/images/Rabbit--Mouse-IgG-Isotype-Control-Flow-Cytometry-NBP2-24891-img0001.jpg "Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.")